M&A Lawyer in New York: Which Steps Matter Most in M&A Process?

Preliminary legal diligence is not a formality. It identifies whether the target has material undisclosed liabilities, contract restrictions, or regulatory hurdles that will affect purchase price, deal structure, or timeline. In practice, deals that skip this step often face renegotiation or collapse when serious issues emerge during formal due diligence. Courts in New York have repeatedly held that a buyer cannot claim fraud or breach of representations if the buyer had access to information and failed to investigate. This principle cuts both ways: it protects sellers, but it also means that your failure to conduct early due diligence may bar later recourse. A practical example: a buyer in a recent Queens-based acquisition discovered during formal due diligence that the target held a critical commercial lease that required landlord consent for assignment. That consent was uncertain, and the buyer had to renegotiate the entire purchase price downward. Early preliminary review would have flagged this risk and allowed the parties to obtain consent before signing the letter of intent, avoiding months of delay.

Your M&A lawyer should prepare a detailed information request schedule tailored to the target's industry and business model. Generic checklists are a starting point, but the most effective diligence focuses on the specific operational and legal risks in that sector. Request documents in phases: first, corporate governance and capitalization; second, material contracts and compliance; third, tax and financial records; fourth, litigation and regulatory matters. Staggering requests prevents the target from becoming overwhelmed and helps you prioritize follow-up questions as information arrives.

Establish clear confidentiality protocols upfront. A confidentiality agreement should specify which employees and advisors can access the data room, how long they may retain documents, and what happens to information if the deal fails. New York courts enforce confidentiality agreements strictly, particularly in M&A contexts where sensitive business information is at stake. Separate sensitive financial and tax data from operational and commercial information, allowing different diligence team members to access only what they need. This discipline protects the seller's interests and also reduces the risk that the buyer will later claim it was misled by information it never actually reviewed.

During diligence, you will encounter issues that range from minor to material. Your M&A lawyer should help you distinguish between items that are negotiable (price adjustments, indemnification baskets, survival periods) and items that are deal-breakers (undisclosed litigation, regulatory non-compliance, material contract terminations). If a deal-breaker emerges, address it immediately with the seller rather than hoping it will resolve during negotiations. Transparency at this stage often preserves the relationship and allows the parties to restructure the deal rather than walk away entirely.

If the transaction meets certain size thresholds (currently, aggregate transaction value above approximately $111 million), the parties must file a Hart-Scott-Rodino (HSR) notification with the Federal Trade Commission and Department of Justice. The HSR process typically requires a 30-day waiting period, which may be extended if the agencies issue a second request. Failure to file, or filing incorrectly, can result in federal enforcement action. Beyond HSR, you must assess whether the transaction raises antitrust concerns under federal or New York state law. A horizontal merger (competitor acquiring competitor) faces higher scrutiny than a vertical or conglomerate transaction. Courts and agencies focus on whether the transaction will substantially lessen competition or create barriers to entry.

Depending on the target's industry, New York State agencies may require approval. Banking and insurance transactions are subject to New York Department of Financial Services (NYDFS) review. Healthcare acquisitions may require review under New York Public Health Law if the target operates licensed facilities. Real estate transactions involving brokers may implicate New York Broker Fee Caps regulations depending on the deal structure. Your M&A lawyer should identify all applicable state and local approvals and build them into the closing condition matrix. Regulatory approval delays are common, and your purchase agreement should include provisions for how long the parties will wait and what happens if approval is denied.

A basket is a threshold: the buyer cannot claim indemnification until aggregate losses exceed a specified amount (often 0.1 to 0.5 percent of purchase price). A cap is a ceiling: the buyer's total recovery is limited to a percentage of purchase price (often 10 to 15 percent, or sometimes capped at the escrow amount). An escrow is a holdback of a portion of the purchase price, typically 10 to 20 percent, held by a third-party escrow agent for a specified period to secure indemnification claims. The interplay between these three mechanisms determines how much risk the seller retains post-closing. Buyers prefer low baskets, high caps, and long survival periods; sellers prefer the opposite. This negotiation is where deal value is often truly determined, because indemnification directly affects the buyer's net recovery if problems emerge.

Survival periods specify how long each representation and warranty remains in effect after closing. General representations (title, capitalization, authority) typically survive 18 to 24 months. Tax and environmental representations may survive longer (often 3 to 7 years), reflecting the longer discovery periods for these issues. Fundamental representations (organization, authority, capitalization) often survive the full indemnification period or longer. New York courts have held that survival periods are strictly construed: if a representation does not explicitly survive past the stated date, the buyer cannot assert a claim after that date, even if the breach was unknown at the time. This means the survival period language must be precise. A buyer that discovers a breach on the last day of the survival period but cannot quantify damages until weeks later may find its claim time-barred if the agreement does not extend the survival period for claims actually asserted before the deadline.

A bring-down is a final review of the target's legal status as of the closing date. It includes updated searches (UCC, judgment, tax lien), confirmation that no new litigation has been filed, verification that no material contracts have terminated, and reaffirmation of key representations. This step is often abbreviated in smaller deals, but it is where you catch changes that occurred between signing and closing. If a material customer contract terminated, or a key employee resigned, or a lawsuit was filed, you want to know before you close and before you are bound by the purchase agreement.

Your M&A lawyer should help you evaluate whether the transaction structure (asset sale, stock sale, merger) aligns with your post-closing objectives and tax position. This decision affects liability allocation, employee obligations, and tax consequences. By the time you reach closing, this decision should already be made and documented, but final verification ensures consistency across all transaction documents. The most important strategic consideration as you move forward is recognizing that M&A success depends on disciplined sequencing: preliminary diligence before commitment, thorough formal diligence before signing, regulatory planning integrated into the timeline, and clear indemnification allocation to avoid post-closing disputes.